Laura Jean Klesse, MD

  • Pediatric Hematologist/Oncologist, Professor at UT Southwestern Medical Center
  • Languages spoken: English
  • Locations (1)

Biography

Laura Klesse, M.D., Ph.D., is the director of the Neurofibromatosis Program at Children’s Health℠ and specializes in assessing and treating cancer predispositions. She is also a Professor of pediatrics and neurological surgery at UT Southwestern Medical Center.

Dr. Klesse earned her medical and doctoral degrees at UT Southwestern. She completed her residency in pediatrics at Children’s Health and performed her fellowship in pediatric hematology-oncology at UT Southwestern.

Dr. Klesse is one of the few neurofibromatosis specialists in the country. Neurofibromatosis, which causes tumors to form on nerve tissue, is the most common cancer predisposition syndrome in children, and managing this chronic disease requires continuity of care with a focus on screening and access to subspecialists. “As we’ve learned more over the last 10 years about the signaling pathways that get disregulated in neurofibromatosis and in tumors, we now have some specific therapies that we can offer that are directed more toward the pathway that gets disregulated,” she says.

In addition to her research on neurofibromatosis, she is involved with a number of drug development trials as well as studies focused on some of the psychosocial consequences that patients with neurofibromatosis sometimes experience, such as bullying. 

Dr. Klesse is a member of the medical advisory board for the Texas Neurofibromatosis Foundation and for Neurofibromatosis Inc. Her professional memberships include the American Society for Pediatric Hematology/Oncology, the American Society for Clinical Oncology, the Society for Neuro-Oncology and the Children’s Oncology Group.

She is married to neurosurgeon Kevin Morrill, M.D., and they have three children.

As we’ve learned more over the last 10 years about the signaling pathways that get disregulated in neurofibromatosis and in tumors, we now have some specific therapies that we can offer that are directed more toward the pathway that gets dysregulated.

Dr. Klesse

Education and Training

  • Medical School
    • University of Texas Southwestern Medical Center (2001)
  • Residency
    • Children's Medical Center Dallas (2005), Pediatrics
  • Fellowship
    • UT Southwestern Medical Center (HR) (2008), Pediatric Hematology/Oncology
    • UT Southwestern Medical Center at Dallas (2002), Pediatric Hematology/Oncology
  • Board Certification
    • American Board of Pediatrics/Hematology-Oncology

Conditions Treated

Departments and Programs

Locations

More Information
Awards & Honors
Publications
Research Interests
Professional Activities
Provider Affiliate Image